12-67294938-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018448.5(CAND1):c.368-95G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000875 in 1,143,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018448.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAND1 | NM_018448.5 | c.368-95G>T | intron_variant | Intron 3 of 14 | ENST00000545606.6 | NP_060918.2 | ||
CAND1 | NM_001329674.2 | c.296-95G>T | intron_variant | Intron 4 of 15 | NP_001316603.1 | |||
CAND1 | NM_001329675.2 | c.296-95G>T | intron_variant | Intron 4 of 15 | NP_001316604.1 | |||
CAND1 | NM_001329676.2 | c.269-95G>T | intron_variant | Intron 4 of 15 | NP_001316605.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAND1 | ENST00000545606.6 | c.368-95G>T | intron_variant | Intron 3 of 14 | 1 | NM_018448.5 | ENSP00000442318.1 | |||
CAND1 | ENST00000535146.1 | n.-17G>T | upstream_gene_variant | 3 | ||||||
CAND1 | ENST00000540319.5 | n.-82G>T | upstream_gene_variant | 2 | ENSP00000445794.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 8.75e-7 AC: 1AN: 1143240Hom.: 0 Cov.: 13 AF XY: 0.00 AC XY: 0AN XY: 572836
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.